ORF_ID	Contig	Start	Stop	Orientation	Cut_Off	Pass_Bitscore	Best_Hit_Bitscore	Best_Hit_ARO	Best_Identities	ARO	Model_type	SNPs_in_Best_Hit_ARO	Other_SNPs	Drug Class	Resistance Mechanism	AMR Gene Family	Predicted_DNA	Predicted_Protein	CARD_Protein_Sequence	Percentage Length of Reference Sequence	ID	Model_ID	Nudged	Note	Hit_Start	Hit_End	Antibiotic
BGC0000726.1|Alginate_1 # 1 # 1458 # 1 # ID=1_1;partial=10;start_type=Edge;rbs_motif=None;rbs_spacer=None;gc_cont=0.612	BGC0000726.1|Alginate_1 	1	1458	+	Loose	1650	27.7202	Streptococcus agalactiae mprF	31.58	3003774	protein homolog model	n/a	n/a	peptide antibiotic	antibiotic target alteration	defensin resistant mprF	ATGGTCTTCTCGTCCAACGTGTTCCTGTTCCTGTTCTTGCCGATCTTCCTCGGCCTGTACTACTTGAGCGGGCAACGCTATCGCAACCTGCTGCTGCTGATTGCCAGCTACATCTTCTATGCCTGGTGGCGGGTGGACTTCCTTGCACTGTTCGCCGGGGTCACCCTGTGGAACTACTGGATCGGCCTCAAAGTGGGTGCCGCCGGCGTGCGAACCAAACCGGCGCAGCGCTGGCTGCTGCTGGGCGTGGGCGTCGACCTGGCCATCCTCGGCTACTTCAAGTACGCCAACTTCGGCGTCGACAGCCCTGAACGCGATCATGACCTCGTTCGGCCTGGAGCCGTTCATCCTCACCCACGTGCTGCTGCCGATCGGTATCTCGTTCTATATCTTCGAGTCGATCAGCTACATCATCGACGTATACCGCGGCGACACCCCGGCTACCCGCACCTGATCGACTTCGCGGCGTTCGTGGCCATTTTCCCGCACCTGATTGCCGGCCCCGTGTTGCGCTTCAAAGACCTGGTCGACCAGTTCAACAACCGCACCCACACCCTGGACAAGTTCTCCGAAGGCTGCACCCGCTTCATGCAGGGTTTCATCAAGAAAGTGTTCATCGCCGACACCTTGGCGGTGGTGGCCGACCACTGCTTTGCCCTGCAAAATCCGACCACGGGTGATGCCTGGCTGGGCGCGCTGGCCTACACCGCGCAGCTGTACTTTGACTTCAGCGGCTACAGCGACATGGCCATCGGCCTGGGCCTGATGATGGGCTTCCGCTTCATGGAGAATTTCAAGCAGCCGTACATCAGCCAGTCGATTACCGAGTTCTGGCGGCGCTGGCACATCAGCCTGTCGACCTGGCTGCGCGACTACCTGTACATCACCTTGGGCGGTAACCGCAAAGGCACCTTCAACACCTACCGCAACCTGTTCCTGACCATGCTGCTGGGCGGCCTGTGGCACGGCGCCAACTTCACCTACATCATCTGGGGCGCCTGGCACGGCATGTGGCTGGTCATCGAACGCGCGCTGGGCATCGACACCAACCCGCAGCGCTTCAACCCGGTGAAGTGGGCCTTCACCTTCCTGCTGGTGGTGGTGGGCTGGGTGATCTTCCGCGCCGAGAACCTGCATGTGGCCGCCCGCATGTACGGTGCCATGTTCAGCTTTGGCGACTGGCAGCTGTCGGAGCTCAACAGCGCTCAGCTGACCGGCCTGCAAGTGGCCACCCTGATCGTCGCCTACATCTCCCTGGCGTTCTTCGGCCTGCGTGATTTCTACCGCAATGCCAAGCCGACGCCCCAGGCAACTCCGGTGCAGGTCAACAACGACGGCTCCATCGGCCTGGATTGGACCCGGGTGATGACCCGCGCCCTGGTGCTGCTGCTGTTCGTGGCCTCGATCCTCAAGCTTTCGGCGCAAAGCTACTCACCGTTCCTGTACTTCCAGTTCTGA	MVFSSNVFLFLFLPIFLGLYYLSGQRYRNLLLLIASYIFYAWWRVDFLALFAGVTLWNYWIGLKVGAAGVRTKPAQRWLLLGVGVDLAILGYFKYANFGVDSPERDHDLVRPGAVHPHPRAAADRYLVLYLRVDQLHHRRIPRRHPGYPHLIDFAAFVAIFPHLIAGPVLRFKDLVDQFNNRTHTLDKFSEGCTRFMQGFIKKVFIADTLAVVADHCFALQNPTTGDAWLGALAYTAQLYFDFSGYSDMAIGLGLMMGFRFMENFKQPYISQSITEFWRRWHISLSTWLRDYLYITLGGNRKGTFNTYRNLFLTMLLGGLWHGANFTYIIWGAWHGMWLVIERALGIDTNPQRFNPVKWAFTFLLVVVGWVIFRAENLHVAARMYGAMFSFGDWQLSELNSAQLTGLQVATLIVAYISLAFFGLRDFYRNAKPTPQATPVQVNNDGSIGLDWTRVMTRALVLLLFVASILKLSAQSYSPFLYFQF	MLKKLIEKVKSLTSVIKIVFFISVLVLIIVEMIHLKRTISVEQLKSVFGQLSPMNLFLIILVGVIAVLPTTGYDFVLNGLLRTDKSKRYILQTSWCINTFNNLSGFGGLIDIGLRMAFYGKKGQEKSDLREVTRFLPYLISGLSFISVIALIMSHIFHAKASVDYYYLVLIGASMYFPVIYWISGHKGSHYFGDMPSSTRIKLGVVSFFEWGCAAAAFIIIGYLMGIHLPVYKILPLFCIGCAVGIVSLIPGGLGSFELVLFTGFAAEGLPKETVVAWLLLYRLAYYIIPFFAGIYFFIHYLGSQINQRYENVPKELVSTVLQTMVSHLMRILGAFLIFSTAFFENITYIMWLQKLGLDPLQEQMLWQFPGLLLGVCFILLARTIDQKVKNAFPIAIIWITLTLFYLNLGHISWRLSFWFILLLLGLLVIKPTLYKKQFIYSWEERIKDGIIIVSLMGVLFYIAGLLFPIRAHITGGSIERLHYIIAWEPIALATLILTLVYLCLVKILQGKSCQIGDVFNVDRYKKLLQAYGGSSDSGLAFLNDKRLYWYQKNGEDCVAFQFVIVNNKCLIMGEPAGDDTYIREAIESFIDDADKLDYDLVFYSIGQKLTLLLHEYGFDFMKVGEDALVNLETFTLKGNKYKPFRNALNRVEKDGFYFEVVQSPHSQELLNSLEEISNTWLEGRPEKGFSLGYFNKDYFQQAPIALVKNAEHEVVAFANIMPNYEKSIISIDLMRHDKQKIPNGVMDFLFLSLFSYYQEKGYHYFDLGMAPLSGVGRVETSFAKERMAYLVYHFGSHFYSFNGLHKYKKKFTPLWSERYISCSRSSWLICAICALLMEDSKIKIVK	57.26	gnl|BL_ORD_ID|2059|hsp_num:0	2283			402	615	defensin
BGC0000726.1|Alginate_2 # 1469 # 2626 # 1 # ID=1_2;partial=00;start_type=ATG;rbs_motif=GGA/GAG/AGG;rbs_spacer=5-10bp;gc_cont=0.626	BGC0000726.1|Alginate_2 	1469	2626	+	Loose	200	30.0314	vanH gene in vanO cluster	23.26	3002948	protein homolog model	n/a	n/a	glycopeptide antibiotic	antibiotic target alteration	vanH; glycopeptide resistance gene cluster	ATGAACCGCACATTACGCATTACTTACTCCCTGTCGTTCCTCGGTTTGCTGGTGGGCATGGGCGTGTGGTCCACCGGTGGCCTGCAAAGCTTTCAGCGCACCGAGCAGATGACCCTGCTCAACGGCAAGCTGGCCAAGGCCGCCGAGACCCACTACGACGCCGAGTTCCCGATCAAACGCCTGGGCACCAACCTTTGGGCGGCCATGGACTTCAAGCTGTTCAACGAGGGCCGCCCCGGTGTGGTGCTGGGCCGCGACCAGTGGCTGTTCAGCGACGAAGAGTTCAAGCCTACGGCTGGCGCCGAACAACTGATGCAGGAAAACCTGGCGCTGATCCGTGGCGTGCGCGACACCTTGCAGCAGCACGGTAGCCAGCTGGTGCTGGCGATCATCCCGGCCAAGGCGCGCGTCTATTCGGAATACCTGGGCAAGGAGCAGCCGGCCAGCCTGCACGATGACCTGTACAACCAGTTCCATGCCCAGGTGCGCCAGGCCAACGTGTTCGCCCCGGACCTGCAAGCGGCCATGGAACAAGCCAAGGCGCGTGGTCAGGTATTCCTGCGCACCGACACCCACTGGACACCGATGGGCGCCGAAGTCGTCGCCCAGGCGCTGGCCGAGGCTGTAAGCCGGCAGAACCTGCTCAATGGTGACCCGCAAACCTTCGTCACCGAAGCCGGCAGCACGGCGCCCTACAAAGGCGACCTGACCAACTTCCTGCCACTGGACCCGCTGTTCAGCAACCTGCTGCCGGCCCCGGACAACCTGCAACAACGCAGCACCCGCCCGGCGCAAGCCGCCGCTGAAGGCGATGACGCGCTGTTCGCCAACAACGAGATCCCGGTCGCGCTGGTGGGTACCAGCTACAGCGCCAACCCGCACTGGAACTTCCTCGGCGCGCTGCAACAAGCCCTGCGCAGCGACGTTGCCAATTACGCCGAAGACGGCCATGGCCCGTTGCTGCCAATGCTCAAGTACCTGCAAAGCGATGCCTTTAAAAACGCTGCACCGCAAGTGGTGGTGTGGGAATTCCCCGAACGTTATCTACCCATGAAAAACGACCTCAGCAGCTTCGATCCGCAGTGGATCGCGCAGCTGAAAAACGCCCGTAAATCCGAAGAAAACCTGGCCTTGTCGTCCACCCGGACGAACCACTGA	MNRTLRITYSLSFLGLLVGMGVWSTGGLQSFQRTEQMTLLNGKLAKAAETHYDAEFPIKRLGTNLWAAMDFKLFNEGRPGVVLGRDQWLFSDEEFKPTAGAEQLMQENLALIRGVRDTLQQHGSQLVLAIIPAKARVYSEYLGKEQPASLHDDLYNQFHAQVRQANVFAPDLQAAMEQAKARGQVFLRTDTHWTPMGAEVVAQALAEAVSRQNLLNGDPQTFVTEAGSTAPYKGDLTNFLPLDPLFSNLLPAPDNLQQRSTRPAQAAAEGDDALFANNEIPVALVGTSYSANPHWNFLGALQQALRSDVANYAEDGHGPLLPMLKYLQSDAFKNAAPQVVVWEFPERYLPMKNDLSSFDPQWIAQLKNARKSEENLALSSTRTNH	MSYRDLGLIDSEVIAERRVRALDDSSPSAVPTTGVRVFGCGHDEAVLFREMGTRLGITPSITEEAISETNAELARGNRCISVSHKTQIDNSTLLALSRVGVEYISTRSVGYNHIDVEFAASIGISVGNVDYSPDSVGDYTLMLMLMTVRHAKSIVRRADTHDYRLNDTRGRELRDLTVGVIGTGRIGTAVIDRLQGFGCRVLAHDSGPHASADYVPLDELLRQSDIVTLHTPLTADTHHLLDRQRIDQMKHGAYIVNTGRGPLLDTEALLSALESGRLGGAALDVVEGEEGIFYADCRNRLIENKALVRLQRLPNVLISPHSAYYTDHALNDTVENSLVNCLNFESGRTA	110.00	gnl|BL_ORD_ID|761|hsp_num:0	786			102	483	vancomycin
BGC0000726.1|Alginate_4 # 3328 # 4611 # 1 # ID=1_4;partial=01;start_type=ATG;rbs_motif=GGAG/GAGG;rbs_spacer=5-10bp;gc_cont=0.630	BGC0000726.1|Alginate_4 	3328	4611	+	Loose	450	26.9498	VMB-1	32.5	3005015	protein homolog model	n/a	n/a	carbapenem; cephalosporin; penam	antibiotic inactivation	VMB beta-lactamase	ATGATCCCGGTAATTCTTTCTGGTGGTAGCGGTTCGCGTCTGTGGCCTCTGTCGCGCAAGCAGTTCCCCAAGCAGTTCCTGGCCCTGACCGGCGAACACACCCTGTTCCAGCAAACCCTCGAGCGCCTGGCGTTCGAAGGCATGGACACGCCGATCGTGGTCTGCAACAAGGACCACAAATTCATCGTCCAGGAGCAGCTCGCTGCGCTGAAGCTGGAAACCCAGGGCATCCTGATGGAGCCGTTTGGCCGCAACACCGCGCCGGCCGTGACCATGGCCGCCATGAAACTGGTCAACGAAGGCCGCGACGATCTGATGCTGGTGCTGCCCGCCGACCACGTGATCGACGACCAGAAGGCCCTGCAGCGCGCCCTGGCCTTGGCCACCGTTGCCGCCGAGCGTGGCGAAATGGTGCTGTTCGGCGTACCGGCGACCAAGCCGGAAACCGGCTACGGCTACATCCGCTCCAGCCAGGACGCGCTGCTGCCCGAGGGCGTGGCGCGCGTGGCCCAGTTCGTGGAAAAACCCGACGAAAAACGTGCCGCCGAGTTCGTCCAGGCCGGTGGCTACTTCTGGAACAGTGGCATGTTCCTGTTCCGCGCCAGCCGCTTCCTCGAAGAGCTGAAAAAGCACGATGCCGACATCTACGACACCTGCGTGCTGGCCCTGGAGCGCAGCGAGGAAGAGGACGAGGTACTCAGCATCGATGAAGCGACCTTCGCCTGCTGCCCGGACAACTCCATCGACTACGCGGTGATGGAAAAGACCCAGCGCGCCTGCGTGGTGCCGATGTCGGCCGGCTGGAGCGACGTGGGCTGCTGGTCGTCGCTGTGGGACGTGCACGAGAAGGACGACAACGGCAACGTCACCAAGGGCGACGTGGTGGTGCAGGACAGCCGCAACTGCATGATCCACGGCAACGGCAAGCTGGTGTCGGTGATCGGCCTGGAGAACATCGTGGTGGTCGAGACCAAGGACGCCATGATGATTGCCCACAAGGACAAGGTCCAGGGCGTCAAGCAGATGGTCAAGACCCTCGACGAGCAGGGCCGTACTGAAACCCAGAACCATCTGGAAGTGTATCGCCCGTGGGGCTCGTACGACTCGGTGGACATGGGCGGCCGCTTCCAGGTCAAGCACATCACCGTCAAGCCGGGTGCCAGCCTGTCGCTGCAGATGCACCACCACCGTGCCGAGCACTGGATTGTGGTGTCTGGTACTGCCGAGGTCACCTGTGACGAGAACGTGTTCCTGCTGACCGAGAACCAGTCGACCTACATCCCG	MIPVILSGGSGSRLWPLSRKQFPKQFLALTGEHTLFQQTLERLAFEGMDTPIVVCNKDHKFIVQEQLAALKLETQGILMEPFGRNTAPAVTMAAMKLVNEGRDDLMLVLPADHVIDDQKALQRALALATVAAERGEMVLFGVPATKPETGYGYIRSSQDALLPEGVARVAQFVEKPDEKRAAEFVQAGGYFWNSGMFLFRASRFLEELKKHDADIYDTCVLALERSEEEDEVLSIDEATFACCPDNSIDYAVMEKTQRACVVPMSAGWSDVGCWSSLWDVHEKDDNGNVTKGDVVVQDSRNCMIHGNGKLVSVIGLENIVVVETKDAMMIAHKDKVQGVKQMVKTLDEQGRTETQNHLEVYRPWGSYDSVDMGGRFQVKHITVKPGASLSLQMHHHRAEHWIVVSGTAEVTCDENVFLLTENQSTYIP	MKYIILFLLLIPSIVFANNEGTKELKLKKLSDNVYQHISYKRVEPWGLIGASGLVVINGTEAHMIDTPWTTQGTKQLIEWIEAKGLTIKSAVVTHFHEDASGDIPLLNDLKIKTYATSLTNKLLKLNQKEVSSDEISSNTFEFIDGVASVFYPGAGHTEDNIVVWLPNEKILFGGCFVKSLKNKNLGYTGDANISEWPNSMQKVINRYPDAKLVVPGHGEVGDVSLLKHTQALALSAAASNKKINKD	173.28	gnl|BL_ORD_ID|2747|hsp_num:0	3758			141	261	ceftriaxone; amoxicillin; meropenem; imipenem; ampicillin; cefotaxime
